Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
48.23
-0.55 (-1.13%)
At close: Oct 27, 2025, 4:00 PM EDT
48.59
+0.36 (0.74%)
After-hours: Oct 27, 2025, 7:59 PM EDT
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $544.83M in the quarter ending June 30, 2025, with 72.61% growth. This brings the company's revenue in the last twelve months to $2.01B, up 88.69% year-over-year. In the year 2024, Hims & Hers Health had annual revenue of $1.48B with 69.33% growth.
Revenue (ttm)
$2.01B
Revenue Growth
+88.69%
P/S Ratio
5.28
Revenue / Employee
$1,230,017
Employees
1,637
Market Cap
10.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walmart | 693.15B |
| Costco Wholesale | 275.24B |
| PepsiCo | 92.37B |
| The Procter & Gamble Company | 84.93B |
| Unilever | 70.19B |
| Anheuser-Busch InBev | 58.52B |
| The Coca-Cola Company | 47.66B |
| Philip Morris International | 39.99B |
HIMS News
- 2 days ago - Hims & Hers: Use This Drop Before It's Too Late - Seeking Alpha
- 4 days ago - Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha
- 5 days ago - Looking For The Next Beyond Meat? Here Are The Top 10 Most Shorted Stocks - Benzinga
- 6 days ago - Hims & Hers Q3 Preview: Key Metrics I Want To See For Beating 2030 Guidance - Seeking Alpha
- 7 days ago - Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright - Seeking Alpha
- 7 days ago - Hims & Hers Health: Roller Coaster Gift - Seeking Alpha
- 10 days ago - Why Hims & Hers stock is failing to retain menopause gains and what comes next? - Invezz
- 11 days ago - Hims & Hers Stock's 150% Surge Is All Fundamentals—No Novo, No Problem - Benzinga